Start-up dedicated to developing new antibiotics

Smartbax nominated for Falling Walls award

06-Nov-2023 - It all began with basic research: While conducting laboratory experiments, a team at the Technical University of Munich (TUM) came across an active agent against multidrug-resistant bacteria with a fundamental difference to antibiotics developed to date. The researchers have since established a ...

Pioneering research projects at the 8th Life Science Pitch Day at the IZB

A total of sixteen teams presented their innovative ideas to almost 50 investors at the Munich start-up center.

18-Jul-2023 - On July 13, 2023, the Munich Innovation and Start-up Center for Biotechnology (IZB) organized the 8th Life Science Pitch Day in cooperation with High-Tech Gründerfonds (HTGF), Leaps by Bayer, and Boehringer Ingelheim, which brought together sixteen biotech start-ups and project teams and almost ...

smartbax Announces Seed Financing of €1.2 Million to Develop Next-generation Antibiotics

26-May-2023 - smartbax, a biotech company developing next-generation antibiotics against multi-drug resistant bacteria, announced the close of its seed financing round of €1.2 million from Boehringer Ingelheim Venture Fund (BIVF) and High-Tech Gründerfonds (HTGF), bringing smartbax’s total capital raised to ...